NIVF
NIVF
NASDAQ · Health Care

Newgenivf Group Ltd-A

$0.53
+0.01 (+1.41%)
As of Jun 30, 5:11 PM ET ·
Financial Highlights (FY 2026)
Revenue
175.79M
Net Income
367.45M
Gross Margin
20.2%
Profit Margin
209.0%
Rev Growth
D/E Ratio
0.16
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 20.2% 63.4% 63.4% 63.4%
Operating Margin 231.2% 15.0% 13.3% 13.3%
Profit Margin 209.0% 10.4% 12.9% 12.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 175.79M 401.7K 362.7K 344.3K
Gross Profit 35.55M 254.9K 230.1K 218.5K
Operating Income 406.43M 60.1K 48.3K 45.7K
Net Income 367.45M 41.8K 46.7K 41.5K
Gross Margin 20.2% 63.4% 63.4% 63.4%
Operating Margin 231.2% 15.0% 13.3% 13.3%
Profit Margin 209.0% 10.4% 12.9% 12.1%
Rev Growth +17.6% -6.2% -6.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 396.4K 153.4K 184.7K 169.1K
Total Equity 2.42M 435.1K 422.0K 475.1K
D/E Ratio 0.16 0.35 0.44 0.36
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 413.43M 62.8K 66.4K 61.5K
Free Cash Flow 54.6K 52.4K 38.3K